BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1979704)

  • 1. Molecular analysis of the pathogenesis of beta-cell destruction in insulin-dependent diabetes mellitus.
    Lernmark A; Bärmeier H; Dube S; Hagopian W; Karlsen AE; Markholst H; Wilson C; Wassmuth R
    West J Med; 1990 Nov; 153(5):499-502. PubMed ID: 1979704
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus.
    Todd JA; Bell JI; McDevitt HO
    Nature; 1987 Oct 15-21; 329(6140):599-604. PubMed ID: 3309680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism and genetic control of the autoimmune response directed against beta-pancreatic cells in insulin-dependent diabetes].
    Michelsen B; Baekkeskov S; Deufel T; Kastern W; Kofod H; Lernmark A; Vissing H
    Journ Annu Diabetol Hotel Dieu; 1985; ():171-82. PubMed ID: 2577960
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoreactivity to a 64,000 Mr human islet cell antigen in sera from insulin-dependent diabetes mellitus patients and individuals with abnormal glucose tolerance.
    Baekkeskov S
    Mol Biol Med; 1986 Apr; 3(2):137-42. PubMed ID: 3526081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA DQ alpha/beta molecule associated with the susceptibility to insulin-dependent diabetes mellitus. A model for HLA/autoimmune disease association.
    Khalil I; Deschamps I; Lepage V; Morin L; Galibert F; Degos L; Hors J
    Nouv Rev Fr Hematol (1978); 1990; 32(6):445-7. PubMed ID: 2101877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies in type 1 diabetes.
    Taplin CE; Barker JM
    Autoimmunity; 2008 Feb; 41(1):11-8. PubMed ID: 18176860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pathogenesis of type 1 diabetes mellitus].
    Schönle EJ
    Ther Umsch; 1990 Jan; 47(1):15-21. PubMed ID: 2408178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restriction fragment polymorphisms of the HLA-DR, HLA-DQ, and insulin gene regions in IDDM: the GAW5 data.
    Cox NJ; Gogolin KJ; Horvath VJ; Barker DF; Wright E; Tran T; Skolnick MH; Boehm BO; Fehsel K; Bertrams J
    Genet Epidemiol; 1989; 6(1):21-6. PubMed ID: 2567259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular properties of HLA-DQ alleles conferring susceptibility to or protection from insulin-dependent diabetes mellitus: keys to the fate of islet beta-cells.
    Moustakas AK; Papadopoulos GK
    Am J Med Genet; 2002 May; 115(1):37-47. PubMed ID: 12116175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis of insulin-dependent diabetes mellitus.
    Atkinson MA; Maclaren NK
    N Engl J Med; 1994 Nov; 331(21):1428-36. PubMed ID: 7969282
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunogenetic mechanisms in the pathogenesis of type 1 diabetes mellitus].
    Tatoń J; Czech A; Podgórski G
    Pol Tyg Lek; 1984 Aug; 39(34):1141-6. PubMed ID: 6390380
    [No Abstract]   [Full Text] [Related]  

  • 12. The same HLA-DQ alleles determine either susceptibility or resistance to different coxsackievirus-mediated autoimmune diseases.
    Luppi P; Alexander A; Bertera S; Noonan K; Trucco M
    J Biol Regul Homeost Agents; 1999; 13(1):14-26. PubMed ID: 10432437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autoimmunity and insulin-dependent diabetes mellitus. Experimental data and therapeutic prospects].
    Thivolet C; Khallouf E
    Pediatrie; 1989; 44(4):247-57. PubMed ID: 2677968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular biological aspects of the pathogenesis of diabetes mellitus].
    Pankov IuA; Chekhranova MK; Keda IuM; Gorskova VA; Kondrat'ev IaIu
    Vestn Akad Med Nauk SSSR; 1989; (5):5-17. PubMed ID: 2667269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autoantibodies in type 1 diabetes mellitus].
    Ziegler M; Ziegler B
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):561-5. PubMed ID: 7856261
    [No Abstract]   [Full Text] [Related]  

  • 16. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
    Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L
    Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Etiology and pathogenesis of type I diabetes].
    Ziegler AG
    Z Gesamte Inn Med; 1993 Mar; 48(3):100-7. PubMed ID: 8475631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele.
    Gianani R; Verge CF; Moromisato-Gianani RI; Yu L; Zhang YJ; Pugliese A; Eisenbarth GS
    J Autoimmun; 1996 Jun; 9(3):423-5. PubMed ID: 8816981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of the inadequate expression of HLA class-II molecules on pancreatic beta cells in the pathogenesis of type-1 diabetes mellitus].
    Manov A
    Vutr Boles; 1991; 30(1):14-8. PubMed ID: 1771854
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: "Autoimmunity and genetics contribute to the risk of insulin-dependent diabetes mellitus in families: islet cell antibodies and HLA DQ heterodimers".
    Breslow NE
    Am J Epidemiol; 1993 Nov; 138(10):905-8. PubMed ID: 8237977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.